LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial-Reference-Cited by-同舟云学术

LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial

Published:2012-07-04 Issue:2 Volume:92 Page:158-169
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Zambrowicz B,Freiman J,Brown P M,Frazier K S,Turnage A,Bronner J,Ruff D,Shadoan M,Banks P,Mseeh F,Rawlins D B,Goodwin N C,Mabon R,Harrison B A,Wilson A,Sands A,Powell D R

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference58 articles.

1. Projecting the Future Diabetes Population Size and Related Costs for the U.S.

2. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

3. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

5. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

Cited by 216 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of the Potential Role of Sotagliflozin: A Dual SGLT2 and SGLT1 Inhibitor—in the Treatment of Heart Failure;Journal of Pharmacy Technology;2024-07-27

2. The Off-Target Cardioprotective Mechanisms of Sodium–Glucose Cotransporter 2 Inhibitors: An Overview;International Journal of Molecular Sciences;2024-07-14

3. Synthetic approaches and clinical application of small-molecule inhibitors of sodium-dependent glucose transporters 2 for the treatment of type 2 diabetes mellitus;European Journal of Medicinal Chemistry;2024-04

4. Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought?;Pharmaceutics;2024-03-24

5. Synthesis and clinical application of new drugs approved by FDA in 2023;European Journal of Medicinal Chemistry;2024-02